Dissolution enhancement of tadalafil by liquisolid technique

References

• Ali N, Hentzschel CM, Leopold CS. Drug release from liquisolid systems: speed it up, slow it down. Expert Opin Drug Deliv 2011;8:191–205.
   PubMed Web of Science ®Google Scholar
• Löbenberg R, Amidon GL. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm 2000;50:3–12.
   PubMed Web of Science ®Google Scholar
• Norbert R, Müller BW. Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs. Pharm Res 2002;19:1894–900.
   PubMed Web of Science ®Google Scholar
• Hajare AA, Jadhav PR. Improvement of solubility and dissolution rate of indomethacin by solid dispersion in polyvinyl pyrrolidone K30 and poloxomer 188. Asian J Pharm Technol 2012;2:116–22.
   Google Scholar
• Pandey MM, Jaipal A, Charde SY, et al. Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: insight into the role of drug–polymer interactions on drug dissolution. Pharm Dev Technol 2016;21:463–74.
   PubMed Web of Science ®Google Scholar
• Medarevic DP, Kachrimanis K, Mitric M, et al. Dissolution rate enhancement and physicochemical characterization of carbamazepine-poloxamer solid dispersions. Pharm Dev Technol 2016;21:268–76.
   PubMed Web of Science ®Google Scholar
• Javiana L, Teobaldo A, Jacqueline S, et al. Preliminary pharmacokinetic study of different preparations of acyclovir with β-cyclodextrin. J Pharm Sci 2002;91:2593–8.
   PubMed Web of Science ®Google Scholar
• Ahmad J, Kohli K, Mir SR, et al. Formulation of self-nanoemulsifying drug delivery system for telmisartan with improved dissolution and oral bioavailability. J Dispers Sci Technol 2011;32:958–68.
   Web of Science ®Google Scholar
• Ebert WR. Soft gelatin capsules: unique dosage form. Pharm Technol 1977;1:44–50.
   Google Scholar
• Aguiar AJ, Zelmer AJ, Kinkel AW. Deaggregation behavior of a relatively insoluble substituted benzoic acid and its sodium salt. J Pharm Sci 1979;56:1243–52.
   Web of Science ®Google Scholar
• Stella VJ, He Q. Cyclodextrins. Toxicologic Pathology 2008;36:30–42.
   PubMed Web of Science ®Google Scholar
• Asare-Addo K, Šupuk E, Al-Hamidi H, et al. Triboelectrification and dissolution property enhancements of solid dispersions. Int J Pharm 2015;485:306–16.
   PubMed Web of Science ®Google Scholar
• Spireas S, Bolton SM, Liquisolid systems and methods of preparing same. US5968550, 1999.
   Google Scholar
• Walke PS, Pawar AY, Sonawane DD, et al. Liquisolid: A novel technique to enhance solubility and dissolution rate of BCS class II pharmaceuticals. Jur Pharm Res 2011;4:4011–4.
   Google Scholar
• Spireas S, Sadu S. Enhancement of prednisolone dissolution properties using liquisolid compacts. Int J Pharm 1998;166:177–88.
   Web of Science ®Google Scholar
• Sayyad FJ, Tulsankar SL, Kolap UB. Desigh and development of liquisolid compact of candesartan cilexetil to enhance dissolution. Jur Pharm Res 2013;7:381–8.
   Google Scholar
• Hentzschel CM, Alnaief M, Smirnova I, et al. Enhancement of griseofulvin release from liquisolid compacts. Eur J Pharm Biopharm 2012;80:130–5.
   PubMed Web of Science ®Google Scholar
• Javadzadeh Y, Shariati H. Movahhed-Danesh, et al. Effect of some commercial grades of microcrystalline cellulose on flowability, compressibility, and dissolution profile of piroxicam liquisolid compacts. Drug Dev Ind Pharm 2009;35:243–51.
   PubMed Web of Science ®Google Scholar
• El-Say KM, Samy AM, Fetouh MI. Formulation and evaluation of rofecoxib liquisolid tablets. Int J Pharmaceut Sci Rev Res 2010;3:135–42.
   Google Scholar
• Nagabandi VK, Ramarao T, Jayaveera KN. Liquisolid compacts: A novel approach to enhance bioavailability of poorly soluble drugs. Int J Pharm Biol Sci 2011;1:89–102.
   Google Scholar
• Gavali SM, Pacharane SS, Sankpal SV, et al. Liquisolid compact: A new technique for enhancement of drug dissolution. Int J Res Pharm Chem 2011;1:705–13.
   Google Scholar
• Karmarkar AB, Gonjari AD, Hosmani AH, et al. Liquisolid tablets: A novel approach for drug delivery. Int J Health Res 2009;2:45–50.
   Google Scholar
• Javadzadeh Y, Siahi MR, Asnaashari S, et al. An investigation of physicochemical properties of piroxicam liquisolid compacts. Pharm Dev Technol 2007;12:337–43.
   PubMed Web of Science ®Google Scholar
• Elkordy AA, Tan XN, Essa EA. Spironolactone release from liquisolid formulations prepared with Capryol™ 90, Solutol® HS-15 and Kollicoat® SR 30 D as non-volatile liquid vehicles . Eur J Pharm Biopharm 2013;83:203–23.
   PubMed Web of Science ®Google Scholar
• Vranikova B, Gajdziok J. Liquisolid systems and aspects influencing their research and development. Acta Pharm 2013;63:447–65.
   PubMed Web of Science ®Google Scholar
• Javadzadeh Y, Jafari-Navimipour B, Nokhodchi A. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine). Int J Pharm 2007;341:26–34.
   PubMed Web of Science ®Google Scholar
• Hentzschel CM, Alnaief M, Smirnova I, et al. Tableting properties of silica aerogel and other silicates. Drug Dev Ind Pharm 2012;38:462–7.
   PubMed Web of Science ®Google Scholar
• Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 2002;168:1332–6.
   PubMed Web of Science ®Google Scholar
• Wlodarski K, Sawicki W, Kozyra A, et al. Physical stability of solid dispersions with respect to thermodynamic solubility of tadalafil in PVP-VA. Eur J Pharm Biopharm 2015;96:237–46.
   PubMed Web of Science ®Google Scholar
• Badr-Eldin SM, Elkheshen SA, Ghorab MM. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Eur J Pharm Biopharm 2008;70:819–27.
   PubMed Web of Science ®Google Scholar
• Mehanna MM, Motawaa AM, Samaha MW. Tadalafil Inclusion in microporous silica as effective dissolution enhancer: optimization of loading procedure and molecular state characterization. Journal of Pharmaceutical Sciences 2011;100:1805–18.
   PubMed Web of Science ®Google Scholar
• Obeidat WM, Sallam ASA. Evaluation of tadalafil nanosuspensions and their PEG solid dispersion matrices for enhancing its dissolution properties. AAPS PharmSciTech 2014;15:364–74.
   PubMed Web of Science ®Google Scholar
• Mahmoud EB, Nazrul H, Gihan F, et al. Solubility and dissolution enhancement of tadalafil using self-nanoemulsifying drug delivery system. J Oleo Sci 2014;63:567–76.
   PubMed Web of Science ®Google Scholar
• Baek JS, Pham CV, Myung CS, et al. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers. Int J Pharm 2015;495:701–9.
   PubMed Web of Science ®Google Scholar
• Vyas V, Sancheti P, Karekar P, et al. Physicochemical characterization of solid dispersion systems of tadalafil with poloxamer 407. Acta Pharm 2009;59:453–61.
   PubMed Web of Science ®Google Scholar
• Spireas S. Liquisolid systems and methods of preparing same. US Patent 6423339, 2002.
   Google Scholar
• Burra S, Yamsani M, Vobalaboina V. The liquisolid technique: an overview. Braz J Pharm Sci 2011;47:475–82.
   Web of Science ®Google Scholar
• Badawy MA, Kamel AO, Sammour OA. Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study. Drug Deliv 2014;1:1–10.
   Web of Science ®Google Scholar
• British Pharmacopoeia, 2013.
   Google Scholar
• Karmarkar AB, Gonjari ID, Hosmani AH, et al. Dissolution rate enhancement of fenofibrate using liquisolid tablet technique Part II: evaluation of in vitro dissolution profile comparison methods. Lat Am J Pharm 2009;28:538–43.
   Web of Science ®Google Scholar
• Mehanna MM, Motawaa AM, Samaha MW. In sight into tadalafil - block copolymer binary solid dispersion: Mechanistic investigation of dissolution enhancement. Int J Pharm 2010;402:78–88.
   PubMed Web of Science ®Google Scholar
• Nokhodchi A, Javadzadeh Y, Siahishadbad MR, et al. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts. J Pharm Pharm Sci 2005;8:18–25.
   PubMed Web of Science ®Google Scholar
• Anderson NR, Gullapalli RP. Beta-Carboline pharmaceutical compositions. US6841167, 2001.
   Google Scholar
• Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. London: Pharmaceutical Press, 2009:122–5.
   Google Scholar
• Javadzadeh Y, Siahi-Shadbad MR, Barzegar-Jalali M, et al. Enhancement of dissolution rate of piroxicam using liquisolid compacts. Il Farmaco 2005;60:361–5.
   PubMedGoogle Scholar
• Suliman AS, Anderson RJ, Elkordy AA. Norfloxacin as a model hydrophobic drug with unique release from liquisolid formulations prepared with PEG 200 and Synperonic PE/L-61 non-volatile liquid vehicles. Powder Technol 2014;257:156–67.
   Web of Science ®Google Scholar
• Chella N, Shastri N, Tadikonda RR. Use of the liquisolid compact technique for improvement of the dissolution rate of valsartan. Acta Pharmaceutica Sinica B 2012;2:502–8.
   Google Scholar
• Abdou HM. Effect of the physicochemical properties of the drug on dissolution. In dissolution, bioavailability and bioequivalence. Mack Pub Co: Easton PA, 1989:53–72.
   Google Scholar
• Fahmy RH, Kassem MA. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. Eur J Pharm Biopharm 2008;69:993–1003.
   PubMed Web of Science ®Google Scholar
• Kumar D, Sailaja Chirravuri SV, Shastri NR. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac. Int J Pharm 2014;461:459–68.
   PubMed Web of Science ®Google Scholar
• Nokhodchi A, Aliakbar R, Desai S, et al. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release. Colloids Surf B Biointerfaces 2010;79:262–9.
   PubMed Web of Science ®Google Scholar
• Javadzadeh Y, Musaalrezaei L, Nokhodchi A. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices. Int J Pharm 2008;362:102–8.
   PubMed Web of Science ®Google Scholar
• Akinlade B, Elkordy AA, Essa EA, et al. Liquisolid systems to improve the dissolution of furosemide. Sci Pharm 2010;78:325–44.
   PubMedGoogle Scholar
• NOYES AA, WHITNEY WR. The rate of solution of solid substances in their own solutions. Am Chem Soc 1897;19:930–4.
   Google Scholar
• Schülke M, Kiss G, Paulus H, et al. Enhancement of dissolution rate of indomethacin using liquisolid compacts. Iran J Pharm Res 2011;10:25–34.
   PubMed Web of Science ®Google Scholar
• Patel NK, Upadhyay AH, Bergum JS, et al. An evaluation of microcrystalline cellulose and lactose excipients using an instrumented single station tablet press. Int J Pharm 1994;110:203–10.
   Web of Science ®Google Scholar
• El-Say KM, Samy AM, Fetouh MI. Formulation and evaluation of rofecoxib liquisolid tablets. Int J Pharm Sci 2010;3:135–42.
   Google Scholar
• Spireas S, Wang T, Grover R. Effect of powder substrate on the dissolution properties of methyclothiazide liquisolid compacts. Drug Dev Ind Pharm 1999;25:163–8.
   PubMed Web of Science ®Google Scholar
• Dahlberg C, Millqvist-Fureby A, Schuleit M, et al. Polymer-drug interactions and wetting of solid dispersions. Eur J Pharm Sci 2010;39:125–33.
   PubMed Web of Science ®Google Scholar
• Muster TH, Prestige CA. Water adsorption kinetics and contact angles of pharmaceutical powders. J Pharm Sci 2005;94:861–72.
   PubMed Web of Science ®Google Scholar
• Boiret M, Rutledge DN, Gorretta N. Application of independent component analysis on Raman images of a pharmaceutical drug product: pure spectra determination and spatial distribution of constituents. J Pharm Biomed Anal 2014;90:78–84.
   PubMed Web of Science ®Google Scholar
• Ward S, Perkins M, Zhang J, et al. Identifying and mapping surface amorphous domains. Pharm Res 2005;22:1195–202.
   PubMed Web of Science ®Google Scholar
• Balazs V, Istvan F, Attila F, et al. Characterization of drug–cyclodextrin formulations using Raman mapping and multivariate curve resolution. J Pharm Biomed Anal 2011;56:38–44.
   PubMed Web of Science ®Google Scholar
• Trefi S, Routaboul C, Hamieh S. Analysis of illegally manufactured formulations of tadalafil (Cialis) by 1H NMR, 2D DOSY 1H NMR and Raman spectroscopy. J Pharm Biomed Anal 2008;47:103–13.
   PubMed Web of Science ®Google Scholar